Shaw Christine
Insider CIK 1820518 · GNMK VP, Assay Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GNMK GenMark Diagnostics, Inc. | D To issuer deriv | 2021-04-22 | 2021-04-22 | 17,500 | — | $0 | 0 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | U Tender | 2021-04-22 | 2021-04-22 | 101,324 | $24.05 | $2.44M | 0 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | F Tax w/h | 2021-04-01 | 2021-04-06 | 1,730 | — | $0 | 100,466 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2021-03-05 | 2021-03-08 | 274 | $18.56 | $5.1K | 102,196 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2021-02-26 | 2021-03-01 | 3,151 | $17.03 | $53.7K | 102,470 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2021-02-24 | 2021-02-25 | 259 | $19.12 | $5.0K | 105,621 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2021-02-23 | 2021-02-25 | 166 | $19.35 | $3.2K | 105,880 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 8,750 | — | $0 | 8,750 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2021-02-18 | 2021-02-22 | 26,250 | — | $0 | 106,046 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2021-01-27 | 2021-01-29 | 81 | $14.06 | $1.1K | 79,796 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2020-12-07 | 2020-12-09 | 274 | $13.97 | $3.8K | 79,877 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2020-11-24 | 2020-11-25 | 355 | $13.17 | $4.7K | 79,291 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2020-10-27 | 2020-10-29 | 68 | $11.34 | $771 | 79,646 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2020-09-08 | 2020-09-10 | 285 | $11.02 | $3.1K | 79,714 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | S Sale | 2020-08-25 | 2020-08-26 | 379 | $14.14 | $5.4K | 79,999 | SEC↗ |